[Smart Drug Delivery Systems Based on Nanoscale ZnO]

Overview

Journal Sheng Wu Yi Xue Gong Cheng Xue Za Zhi

Specialty Biomedical Engineering

Date 2018 May 11

PMID 29745542

Authors

Xiao Huang

Chun Chen

Caixia Yi

Xi Zheng

Affiliations

Soon will be listed here.

Abstract

In view of the excellent biocompatibility as well as the low cost, nanoscale ZnO shows great potential for drug delivery application. Moreover, The charming character enable nanoscale ZnO some excellent features (e.g. dissolution in acid, ultrasonic permeability, microwave absorbing, hydrophobic/hydrophilic transition). All of that make nanoscale ZnO reasonable choices for smart drug delivery. In the recent decade, more and more studies have focused on controlling the drug release behavior via smart drug delivery systems based on nanoscale ZnO responsive to some certain stimuli. Herein, we review the recent exciting progress on the pH-responsive, ultrasound-responsive, microwave-responsive and UV-responsive nanoscale ZnO-based drug delivery systems. A brief introduction of the drug controlled release behavior and its effect of the drug delivery systems is presented. The biocompatibility of nanoscale ZnO is also discussed. Moreover, its development prospect is looked forward.

References

Huang X, Lu J, Yue D, Fan Y, Yi C, Wang X . Fe₃O₄@ZnO core-shell nanocomposites for efficient and repetitive removal of low density lipoprotein in plasma and on blood vessel. Nanotechnology. 2015; 26(12):125101. DOI: 10.1088/0957-4484/26/12/125101. View

Tripathy N, Ahmad R, Ko H, Khang G, Hahn Y . Enhanced anticancer potency using an acid-responsive ZnO-incorporated liposomal drug-delivery system. Nanoscale. 2015; 7(9):4088-96. DOI: 10.1039/c4nr06979j. View

Qiu H, Cui B, Zhao W, Chen P, Peng H, Wang Y . A novel microwave stimulus remote controlled anticancer drug release system based on FeO@ZnO@mGdO:Eu@P(NIPAm-co-MAA) multifunctional nanocarriers. J Mater Chem B. 2020; 3(34):6919-6927. DOI: 10.1039/c5tb00915d. View

Zhang H, Guo L, Ding S, Xiong J, Chen B . Targeted photo-chemo therapy of malignancy on the chest wall while cardiopulmonary avoidance based on Fe3O4@ZnO nanocomposites. Oncotarget. 2016; 7(24):36602-36613. PMC: 5095024. DOI: 10.18632/oncotarget.9123. View

Chen T, Zhao T, Wei D, Wei Y, Li Y, Zhang H . Core-shell nanocarriers with ZnO quantum dots-conjugated Au nanoparticle for tumor-targeted drug delivery. Carbohydr Polym. 2013; 92(2):1124-32. DOI: 10.1016/j.carbpol.2012.10.022. View

Fini M, Tyler W . Transcranial focused ultrasound: a new tool for non-invasive neuromodulation. Int Rev Psychiatry. 2017; 29(2):168-177. DOI: 10.1080/09540261.2017.1302924. View

Rakhshaei R, Namazi H . A potential bioactive wound dressing based on carboxymethyl cellulose/ZnO impregnated MCM-41 nanocomposite hydrogel. Mater Sci Eng C Mater Biol Appl. 2017; 73:456-464. DOI: 10.1016/j.msec.2016.12.097. View

Vimala K, Shanthi K, Sundarraj S, Kannan S . Synergistic effect of chemo-photothermal for breast cancer therapy using folic acid (FA) modified zinc oxide nanosheet. J Colloid Interface Sci. 2016; 488:92-108. DOI: 10.1016/j.jcis.2016.10.067. View

Karimi M, Ghasemi A, Zangabad P, Rahighi R, Moosavi Basri S, Mirshekari H . Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev. 2016; 45(5):1457-501. PMC: 4775468. DOI: 10.1039/c5cs00798d. View

10.

Shi Y, Ma C, Du Y, Yu G . Microwave-responsive polymeric core-shell microcarriers for high-efficiency controlled drug release. J Mater Chem B. 2020; 5(19):3541-3549. DOI: 10.1039/c7tb00235a. View

11.

Huang X, Wang X, Wang S, Yang J, Zhong L, Pan J . UV and dark-triggered repetitive release and encapsulation of benzophenone-3 from biocompatible ZnO nanoparticles potential for skin protection. Nanoscale. 2013; 5(12):5596-601. DOI: 10.1039/c3nr00090g. View

12.

Kong F, Huang X, Yue D, Pan J . A biocompatible and magnetic nanocarrier with a safe UV-initiated docetaxel release and cancer secretion removal properties increases therapeutic potential for skin cancer. Mater Sci Eng C Mater Biol Appl. 2017; 76:579-585. DOI: 10.1016/j.msec.2017.03.078. View

13.

Liu J, Zhao Y, Ge W, Zhang P, Liu X, Zhang W . Oocyte exposure to ZnO nanoparticles inhibits early embryonic development through the γ-H2AX and NF-κB signaling pathways. Oncotarget. 2017; 8(26):42673-42692. PMC: 5522097. DOI: 10.18632/oncotarget.17349. View

14.

Fouladi F, Steffen K, Mallik S . Enzyme-Responsive Liposomes for the Delivery of Anticancer Drugs. Bioconjug Chem. 2017; 28(4):857-868. PMC: 5509414. DOI: 10.1021/acs.bioconjchem.6b00736. View

15.

Saptarshi S, Duschl A, Lopata A . Biological reactivity of zinc oxide nanoparticles with mammalian test systems: an overview. Nanomedicine (Lond). 2015; 10(13):2075-92. DOI: 10.2217/nnm.15.44. View

16.

Ivask A, Juganson K, Bondarenko O, Mortimer M, Aruoja V, Kasemets K . Mechanisms of toxic action of Ag, ZnO and CuO nanoparticles to selected ecotoxicological test organisms and mammalian cells in vitro: a comparative review. Nanotoxicology. 2013; 8 Suppl 1:57-71. DOI: 10.3109/17435390.2013.855831. View

17.

Muhammad F, Guo M, Qi W, Sun F, Wang A, Guo Y . pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids. J Am Chem Soc. 2011; 133(23):8778-81. DOI: 10.1021/ja200328s. View

18.

Wang Y, Song S, Liu J, Liu D, Zhang H . ZnO-functionalized upconverting nanotheranostic agent: multi-modality imaging-guided chemotherapy with on-demand drug release triggered by pH. Angew Chem Int Ed Engl. 2014; 54(2):536-40. DOI: 10.1002/anie.201409519. View

19.

Kanmani P, Rhim J . Properties and characterization of bionanocomposite films prepared with various biopolymers and ZnO nanoparticles. Carbohydr Polym. 2014; 106:190-9. DOI: 10.1016/j.carbpol.2014.02.007. View

20.

Ye D, Ma Y, Zhao W, Cao H, Kong J, Xiong H . ZnO-Based Nanoplatforms for Labeling and Treatment of Mouse Tumors without Detectable Toxic Side Effects. ACS Nano. 2016; 10(4):4294-300. DOI: 10.1021/acsnano.5b07846. View